RE:RE:RE:also 🚩MrMugsy wrote: Agree Montana5.
The only thing I'd add for thought/discussion is ... I've been watching the stock for a long time now and it doesn't take much for people to swing the share price.
There really aren't many trading here and its the same old crew who've been here, left and come back. Very few new holders - it seems.
I personally won't even entertain the price/value comparison until we see a minimum of 30-40 days where the stock trades over 100K shares per day, each day. 30 days is such a loose number but it gets my point across.
For the stock to be dropping before P2 - just noise. P2 will be interesting to see w.r.t. to where the price goes. We also know that during P2, anxiety and buying/selling can cause the price to be erratic.
I watch this $1.00 warrant period with interest. Is it nothing or is there more news to follow. DILIsym has much more to say about OTENA. Does the company have more to say before P2? To be determined.
It doesn't help that litigation remains open - but - since we didn't hear anything in October ... I am assuming we don't hear anything until after P2. This may remain in limbo for a very long time. So be it. All eyes on the prize and that's P2. Everything else ... at 50 cents or $5.00 ... just noise but I do need to remain mindful of what lower level I become a further accumulator. I don't expect to see that number ever again - but - never say never !!!!!
While the Jan 18 update was timely and informative, if mgt was relying on this alone to strengthen the sp and allow the discounted warrant exercise funds to flow in, they appear to have seriously miscalculated the market.The arbitration was not even mentioned and so it remains a risk and without announcing a positive resolution, it seems very unlikely any warrant holders would exercise even if $1 is recaptured in coming trading days.
Unfortunately, what we're witnessing with the $1 warrants is likely to play out once the discount window expires, meaning it seems very likely management has hamstrung the sp and capped it around $1.50 all the way to July expiry. If I had to guess the second sp thrust, similar to what we saw in Oct/Nov will occur in August, post expiry, leading into the Sept readout IF p2 remains on schedule.
What I really want to hear from management as they approach readout is exactly what are they doing now to proactively linie up partnering/icensing opportunities in a post haste manner on the back of a p2 success. Cash fumes by September are seemingly a given and some form of a dilutive raise is also a given but let's hope for the sake of us long term holders, having experienced so many dilutive raises and scientific setbacks over the years, this management team has not only approached the science with deep due diligence and thoughtfulness but also has a well thought out plan that entails fully financing the ph 3 trial without more than doubling the share count (again).